Alfresa stock holds its ground as fresh figures shape the outlook

Alfresa stock was quoted at a dated Tokyo market level on September 22, 2026, while the company remains defined by its latest reported revenue and operating profit figures. The figures place distribution scale and operating efficiency at the center of the investment case.

Revenue sets the operating base

Alfresa Holdings reported revenue and operating profit for its latest disclosed reporting period in company materials available through its investor-relations information. The reporting period and the comparison with the preceding period are the key measures for assessing whether distribution growth is translating into earnings quality.

Margins remain the key comparison

The operating-profit margin provides the most useful comparison alongside revenue because it shows whether profit is keeping pace with sales. For Alfresa, the combination of revenue growth, operating profit and the corresponding margin is more informative than revenue alone, particularly in a business exposed to logistics costs and pharmaceutical distribution conditions.

Tokyo price remains the market reference

The primary reference for Alfresa is the Tokyo Stock Exchange quotation in Japanese yen. The dated market value on September 22, 2026, should be read together with the latest reported operating figures, because the price reflects the market's assessment of both distribution demand and the company's ability to protect profitability.

More news and analyses on Alfresa stock